Chat with us, powered by LiveChat
2nd Clinical Trials Phase I and Phase II -

2nd Clinical Trials Phase I and Phase II
May 7 - 8, 2015
Boston, MA

2nd Clinical Trials Phase I and Phase IIA Summit – 2nd Clinical Trials Phase I and Phase II

The early phases of a clinical trial are the most crucial. This is where the potential of a drug is evaluated and applied to the treatment at stake. However, they are also the most expensive and regulated portions of a trial. It can cost up to two billion dollars just to complete these early phases of a clinical trial, and sometimes, they are even bypassed. If this does not occur, and a drug does go through Phase I and Phase IIA, corners can be proactively cut in order to decrease costs, meet regulatory requirements and ensure efficacy.

The 2nd Clinical Trials Phase I and Phase IIA Summit will explore paramount strategies behind increasing efficiency in early phase clinical trials. As the early clinical development space is continuously evolving, this must-attend event will feature countless case studies and networking opportunities to address current challenges. In addition to hearing about pharmacokinetic, pharmacogenomic and pharmacovigilant methodologies, this conference will provide the audience with the opportunity to hear from top industry thought leaders in regards to driving success into their clinical trials.

Top Five Reasons to Attend

  1. Identify compound development strategies to optimize success in clinical trials
  2. Learn best practices for early decision-making through analysis of biomarker utility in drug development
  3. Use analytical technology to evaluate multiple configurations of a small molecule to increase the feasibility of Drug in Clinical Trials
  4. Implement adaptive design in proof of concept studies to increase efficiency, decrease time and decrease overall cost
  5. Explore the seamless development of Phase I to Phase II in clinical trials

Who Should Attend

This conference is designed for professionals from the pharmaceutical and biotechnology industries as well as clinical research organizations with responsibilities in the following areas:

  • Clinical Operations/Research
  • Pharmacovigilance/Pharmacokinetics
  • Early Development
  • Early Phase Research
  • Formulation
  • Compound Development
  • Chief Science Officer/Senior Scientists
  • Biologics
  • Clinical Development Statistics
  • Clinical Informatics
  • Outsourcing
  • Product Development
  • Drug Safety
  • Trial Design Management
  • Clinical Regulatory Affairs/Compliance/Outsourcing
  • Medical Research/Affairs
  • Translational Science/Medicine

This event is also of interest to:

  • Contract Research Organizations
live chat software